Posted by AGORACOM-JC
at 2:39 PM on Monday, December 9th, 2019
SPONSOR: New Age Metals Inc.
The company owns one of North America’s largest primary platinum
group metals deposit in Sudbury, Canada. Updated NI 43-101 Mineral
Resource Estimate 2,867,000 PdEq Measured and Indicated Ounces, with an
additional 1,059,000 PdEq Ounces in the Inferred. Learn More.
Palladium eyes $1,900 in record surge, gold firms on trade doubts
Palladium soared to a record just shy of the $1,900 mark on Monday
Gold edged higher as uncertainty over U.S.-China trade talks took center stage ahead of a Dec. 15 deadline for fresh U.S. tariffs.
Autocatalyst metal palladium climbed to an all-time high of $1,898.50 an ounce and was last up 0.19% at $1,881.43.
“Palladium has a very strong fundamental backdrop with supply set to
stay quite scarce and demand growth set to increase,†said Daniel Ghali,
commodity strategist at TD Securities.
Palladium has risen nearly 50% in 2019 on a sustained supply squeeze,
and has constantly been breaking records, despite a weakening global
auto sector. Increasingly stringent emissions regulations globally are
raising the palladium in autocatalysts for gasoline-powered cars and
2020 could see the most number of regulations, Ghali added.
“There is a widespread expectation that (palladium) spot prices are
headed towards $2,000 and the market does currently appear to be in a
one-way street,†INTL FCStone analyst Rhona O’Connell said in a note.
“Even with the (auto) sector under pressure, palladium will be in
deficit for the foreseeable future and the funds are chasing it higher.â€
“The tariff deadline of Dec. 15 is certainly top of everyone’s mind
… The situation is still uncertain, helping gold stay firm,†TD
Securities’ Ghali said. China said on Monday it hoped to make a trade
deal with the United States as soon as possible, as Washington’s next
round of tariffs against Chinese goods is scheduled to take effect on
Dec. 15. Also supporting bullion, equity markets were further pressured
after China’s exports shrank in November.
Markets now await the U.S. Federal Reserve’s two-day meeting starting
on Tuesday for cues on its monetary policy. The central bank is
expected to highlight the economy’s resilience and keep interest rates
on hold in the range of 1.50% to 1.75%.
U.S. investment bank Goldman Sachs said investment demand for gold
would be supported by recession fears and political uncertainty,
forecasting prices at $1,600 an ounce over a three- and 12-month period.
Platinum and silver were up 0.2% at $897.36 and $16.60 an ounce, respectively.
Posted by AGORACOM-JC
at 12:19 PM on Monday, December 9th, 2019
SPONSOR:ThreeD Capital Inc. (IDK:CSE)
Led by legendary financier, Sheldon Inwentash, ThreeD is a
Canadian-based venture capital firm that only invests in best of breed
small-cap companies which are both defensible and mass scalable. More
than just lip service, Inwentash has financed many of Canada’s biggest
small-cap exits. Click Here For More Information.
5 Crypto Trends that Appeared in 2019
The crypto space evolved in 2019, moving a bit beyond the immediate hype of price action.
While some trends and approaches failed, other developments came into the spotlight, offering new types of earnings opportunities.
The crypto space evolved in 2019, moving a bit beyond the immediate
hype of price action. While some trends and approaches failed, other
developments came into the spotlight, offering new types of earnings
opportunities.
In 2019, the top crypto trends expanded to fill the void of previously defunct models.
Futures Trading: The CME futures trading started
back in 2017. But in 2019, the market had grown significantly. The
launch of Bakkt futures added to the price discovery of Bitcon (BTC) at
the end of 2019. Crypto-to-crypto exchanges also expanded their futures
markets in many directions. Some chose to offer futures for the most
liquid altcoins. OKEx was among the most innovative markets, adding
USDT-settled futures.
The addition of futures also meant that not only BTC owners could
hope to trade based on the price risk of the leading coin. Futures
markets move by a different logic, and do not need to conform to the
expectations of long-term BTC “hodlersâ€, hence pressures to dump the
price are also possible.
Crypto-based Lending: As more altcoins became
inactive, the assets had to find a use case. Lending based on locking up
the assets expanded in 2019. Ethereum (ETH) was the top collateral
asset. Binance, however, became the leader in offering lending products
based on some of the leading altcoins.
Custodial Storage and Staking: Staking coins were
big even years ago, but for most, this required some technical knowledge
and a dedication to keeping an operational wallet online. Now, it is
possible to stake coins while making use of custodial services. Coinbase
and more recently, Binance, are adding more proof-of-stake coins,
redistributing the rewards. The latest asset to be added was Tezos,
which has a relatively complex “baking†process.
Decentralized Finance (DeFi): Part crypto lending,
part staking, DeFi is a separate rendition for the usage of stablecoins.
Usually based on Ethereum (ETH), those services aim to replicate
traditional finance. Maker DAO grew significantly in 2019, finally
releasing its multi-collateral DAI in November. Despite ETH price
volatility, DeFi only suffered relatively minor liquidations, and trust
remained high enough to continue the decentralized lending pattern.
IEOs: Initial Exchange Offerings were the tamer,
curated version of token sales. At the lead, exchanges like Binance and
OKEx offered independent projects. Binance went the extra mile to build
its own Binance Chain and host some of the tokens. Returns from IEOs
varied, and some exchanges rode the trend with shady offerings. Bitfinex
also used the IEO hype to place its own LEO token, which did not hold a
public sale. IEOs were a new opportunity for tokenization and financing
selected projects, but most of the tokens were volatile.
For almost all crypto trends, 2020 may see even stricter regulations.
But financial innovation is happening in the sector, potentially
building new cases for digital assets.
Posted by AGORACOM-JC
at 10:09 AM on Monday, December 9th, 2019
Zomato CEO Deepinder Goyal, CEO of BetterU Brad Loiselle &
Beautiful Destinations CEO Jeremy Jauncey spoke at the 17th edition of
Hindustan Times Leadership Summit. They spoke on changing the way of
doing business in India and also highlighted the challenges they face in
the country. They also spoke on the role of social media in
establishing and running a business in India and narrated the
differences between operating a business in India and abroad. Watch the
full video for more.
KEY 2020 PUREVAP™ DEVELOPMENTS THAT WILL DRIVE HPQ FORWARD
1. Gen 3 PUREVAP™ QRR Pilot Plant operational Q1 2020
PyroGenesis Canada Inc.(TSX-V: PYR) (“PyroGenesisâ€) informed HPQ that the Pilot Plant commissioning and testing program will start in full force Q1 2020.
“As previously discussed, a good part of the past year saw us
divert assets from paying projects to non-paying projects. This enabled
PyroGenesis to secure the large breakout contract it recently announced
as well as the upcoming Navy project, which was also recently
announced. As a result, our signed backlog increased from $6MM in Q2
2019 to almost $30MM at the end of Q3 2019. The successful closing of
the Navy project will further increase this backlog by an additional
$13MM. This increase in backlog de risks the company significantly, all
to the benefit of our clients, like HPQ, and their shareholders,†said P. Peter Pascali, President and CEO of PyroGenesis Canada Inc.
“We are now in position to re-focus, and accelerate, the PUREVAP
initiative focus on the multitude of opportunities that have come to
light since defining our original mandate. As a result, we are
confident that HPQ is going to make some significant headway over the
coming months, the least of which will be to start the Gen3 PUREVAPTMPlant commissioning and testing program.
“HPQ congratulates our partner P. Peter Pascali and his
PyroGenesis team on their $20 million contract award, which once again
proves their ability to commercialize high tech applications on a global
scale,†said Bernard Tourillon, President & CEO of HPQ Silicon. “With
the PUREVAPTM Pilot Plant becoming operational in Q1 2020, we now have
even greater confidence in our joint ability to deliver the critical
Silicon material required by the surging Li-ion battery market in 2020
and beyond.â€
The PUREVAP™QRR technology is a unique
carbothermic process that will allow HPQ to have a significant impact,
short and long term, on the following Silicon (Si) markets and
industries:
2. Nanoscale Structure Silicon Powders manufacturing for Li-ion batteries
HPQ and PyroGenesis recently announced plans
regarding the creation of a Joint Venture to produce Nanoscale
Structure Silicon (Si) powders for Li-ion batteries. In Q1 2020, the
plan is to have a modified Gen2 PUREVAPTM reactor operational,
in parallel with the Pilot Plant, validating that our approach works and
producing Nanoscale Structure Silicon (Si) powders samples for industry
participants and research institutions.
Nanoscale Structure Silicon Powders improve Li-ion battery
performance but high-performance Silicon (Si) anodes made using powders
selling for US$ 30,000/kg1 are not commercially feasible. Combining HPQ
PUREVAP™Quartz Reduction Reactor (“QRR”) technology
with PyroGenesis Plasma Atomization knowhow to produce Nanoscale
Structure Silicon (Si) powders represents a unique multibillion-dollar
business opportunity that could subsequently lead to their wide scale
adoption in the battery market. If this occurs, HPQ and PyroGenesis
would then be well positioned to assume a dominant market position.
Silicon’s potential to meet energy storage demand is undeniable and generating massive investments, as well as, serious industry interest, so HPQ and PyroGenesis timing could not be better. A recent report
by Wood Mackenzie Power projects that energy storage deployments are
estimated to grow 1,300% from a 12 Gigawatt-hour market in 2018 to a 158
Gigawatt-hour market in 2024. An estimated US$71 billion in
investments will be made into storage systems where batteries will make
up the lion’s share of capital deployment.
3. Porous Silicon wafers for solid state Li-ion Batteries
During Q3 2019, HPQ started discussions with a battery manufacturer regarding using Silicon produced by our Gen3 PUREVAPTM QRR
pilot plant to manufacture porous silicon wafers needed for their
operations. Furthermore, HPQ negotiated with Apollon Solar an amended
agreement that broadens the scope of the 2017 collaboration
to include, going forward, evaluating manufacturing porous Silicon
wafers for solid-state Li-Ion batteries combining their patented process
with Silicon (Si) produced with HPQ PUREVAPTMQRR.
In November 2019,
HPQ and its partner Apollon Solar SAS, acting as one party, signed a
non-disclosure agreement (“NDAâ€) with the battery manufacturer for the
purposes of exchanging technical information and sending testing
materials. We are still at the beginning of the process of exchanging
technical information and yet we are already looking into the
possibility of supplying the battery manufacturer with the first Silicon
wafer for testing by year end or beginning of 2020.
The probabilities that the discussions started under NDA will evolve
during Q1 2020 to a more formal process are very encouraging.
4. High Purity Silicon Oxide (SiOx) Nanopowders for Li-ion Batteries
In addition to its wafer work, HPQ intends to study, during H1 2020,
the possibility of utilizing Apollon Solar patented process to optimize
the porous structure of HPQ PUREVAPTM Silicon between
Microporous (pore size <5nm), Mesoporous (pore size 5nm – 50nm) and
Macroporous (pore size >50nm) in order to evaluate the potential of
producing, low cost, High Purity SiOx Nanopowders.
The infancy of Si anode technology base on Nanoscale Structure
Silicon Powders explains why presently only limited performance
improvement are obtained using High Purity Silicon Oxide (SiOx)
Nanopowders, selling for about US$ 100/kg2, used in a blended form with
graphite in traditional Li-ion batteries. The quantity used is
typically less than 5 wt%
of the material used to make the batteries, yet even at these levels of
utilization, this is estimated to represent an addressable market of US
$ 1B by 20223 expanding at a CAGR of 38.9% between 2019 – 2024.
5. Standard purity Silicon (“Siâ€) (up to 2N Purity)
Up to now, market participants with significant quartz assets have
shown a keen interest in our process. As such, HPQ anticipates silicon
industry participants will show a keen interest in PUREVAPTM once the
Pilot Plant is operational and validates our unique operational
advantages.
The addressable market for Mg Si is in the multi-billion range with
demand projected to increase by a CAGR of 19% over the next 5 years
(US$ 7.5B in 2018 to US$ 12B in 2023)4. The bulk of the growth is
expected to come from the 2N segment of the market, where the PUREVAP™ QRR process should have massive opex and capex advantage over traditional manufacturers.
6. Solar Grade Silicon using a PUREVAPTM UMG metallurgical process
The market for Solar Grade Silicon is massive and evolving at such an
accelerated pace that some of our original product development
hypothesis are not as relevant as before. Having said this, working
with Apollon Solar, we strongly believe that if the PUREVAP™QRR can
produce, as we believe it can, Si material of 4N+ purity with low boron
count (< 1 ppm), we can develop a very competitive UMG Metallurgical
route to produce Solar Grade Silicon.
OTHER CORPORATE NEWS
1. ANNUAL MINIMUM ROYALTIES PAYMENT DUES TO PYROGENESIS
Under the terms of our Agreement with PyroGenesis, HPQ was obliged to
pay minimum royalty payment obligations of $150,000 for 2018 and
$200,000 for 2019. Due to delays in the project beyond HPQ’s control,
PyroGenesis has agreed to wave HPQ minimum royalty payment obligations
for 2018 and 2019. This represents a Q4 2019 reduction in HPQ current
liabilities of $350,000. Minimum royalties’ obligations will resume
with the scheduled 2020 payment to PyroGenesis.
2. WARRANTS EXTENSION
HPQ Board of Directors has authorized the application to the TSX
Venture Exchange (the “Exchangeâ€) for approval of the extension, until
January 31, 2022, of the exercise date of 4,152,000 outstanding common
share purchase warrants (the “Warrantsâ€) issued by the Company July 17,
2018. The 4,152,000 Warrants are set to expire on January 17, 2020 and
have an exercise price of $0.155. As of today, none of these purchase
warrants has been exercised. All other terms and conditions of the
Warrants will remain the same. The proposed extension is conditional
upon the receipt of the approval of the Exchange.
3. DEBT FOR SHARES
In accordance with the agreement between HPQ-Silicon and Agoracom,
entered into on July 15, 2018 for the term ending July 15, 2020,
HPQ-Silicon board has approved the issuance of 156,944 common shares at a
deemed price of 9 cents per share to pay $14,125 for services rendered
during the period from January 16, 2019 ending April 15, 2019, HPQ board
has also approved the issuance of 156,944 common shares at a deemed
price of 9 cents per share to pay $14,125 for services rendered during
the period from April 16, 2019 ending July 15, 2019, and HPQ board has
also approved the issuance of 166,176 common shares at a deemed price of
8.5 cents per share to pay $14,125 for services rendered during the
period from July 16, 2019 ending October 15, 2019. Each share issued
pursuant to the debt settlement will have a mandatory four (4) month and
one (1) day holding period from the date of closing.
About Silicon
Silicon (Si) is one of today’s strategic materials needed to fulfil
the renewable energy revolution presently under way. Silicon does not
exist in its pure state; it must be extracted from quartz, one of the
most abundant minerals of the earth’s crust and other expensive raw
materials in a carbothermic process.
About HPQ Silicon
HPQ Silicon Resources Inc. is a TSX-V listed company developing, in
collaboration with industry leader PyroGenesis (TSX-V: PYR) the
innovative PUREVAPTM “Quartz Reduction Reactors†(QRR), a truly
2.0 Carbothermic process (patent pending), which will permit the
transformation and purification of quartz (SiO2) into Metallurgical
Grade Silicon (Mg-Si) at prices that will propagate its significant
renewable energy potential.
HPQ is also working with industry leader Apollon Solar to develop: Porous silicon wafers manufacturing using PUREVAP™
Silicon (PVAP Si) that can be used as anode for all-solid-state and
Li-ion batteries; and a metallurgical pathway of producing Solar Grade
Silicon Metal (SoG Si) that will take full advantage of the PUREVAPTM QRR
one-step production of high purity silicon (Si) and significantly
reduce the Capex and Opex associated with the transformation of quartz
(SiO2) into SoG-Si.
HPQ focus is becoming the lowest cost producer of Silicon (Si), High
Purity Silicon (Si), Porous Silicon Wafers and Solar Grade Silicon Metal
(SoG-Si). The pilot plant equipment that will validate the commercial
potential of the process is on schedule to start in 2019.
This News Release is available on the company’s CEO Verified Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.
Disclaimers:
The Corporation’s interest in developing the PUREVAP™ QRR and any
projected capital or operating cost savings associated with its
development should not be construed as being related to the establishing
the economic viability or technical feasibility of the Company’s
Roncevaux Quartz Project, Matapedia Area, in the Gaspe Region, Province
of Quebec.
This press release contains certain forward-looking statements,
including, without limitation, statements containing the words “may”,
“plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”,
“expect”, “in the process” and other similar expressions which
constitute “forward-looking information” within the meaning of
applicable securities laws. Forward-looking statements reflect the
Company’s current expectation and assumptions and are subject to a
number of risks and uncertainties that could cause actual results to
differ materially from those anticipated. These forward-looking
statements involve risks and uncertainties including, but not limited
to, our expectations regarding the acceptance of our products by the
market, our strategy to develop new products and enhance the
capabilities of existing products, our strategy with respect to research
and development, the impact of competitive products and pricing, new
product development, and uncertainties related to the regulatory
approval process. Such statements reflect the current views of the
Company with respect to future events and are subject to certain risks
and uncertainties and other risks detailed from time-to-time in the
Company’s on-going filings with the security’s regulatory authorities,
which filings can be found at www.sedar.com. Actual results, events, and
performance may differ materially. Readers are cautioned not to place
undue reliance on these forward-looking statements. The Company
undertakes no obligation to publicly update or revise any
forward-looking statements either as a result of new information, future
events or otherwise, except as required by applicable securities laws.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of this
release.
For further information contact Bernard J. Tourillon, Chairman, President and CEO Tel (514) 907-1011 Patrick Levasseur, Vice-President and COO Tel: (514) 262-9239 http://www.hpqsilicon.com Email: [email protected]
1 Source: Quotation from a producer (Confidential), Media article
2 Advanced Battery Materials, Chapter 5: Practically Relevant Research on Silicon-Based Lithium-Ion Battery Anodes (page 271)
3 Source Marketandmakerts.com
4 CRU – Silicon Market Outlook – November 14, 2018 (Pages 20 – 23)
Posted by AGORACOM-JC
at 7:00 PM on Sunday, December 8th, 2019
Until now, investor participation in Artificial Intelligence has been the domain of mega companies and those funded by Silicon Valley. Small cap investors can finally consider participating in the great future of A.I. through Datametrex AI (DM: TSXV) (Soon To Be Nexaology) who just reported the following:
Q3 Revenues Of $1.6 million, an increase of 186%
9 Mont Revenues Of $2.56M an increase of 37%
A Repeat $1M Contract With A Division Of Korean Giant LOTTE Group Â
$954,000 Contract With Canadian Department of Defence To Fight Social Media Election Meddling
Participation In NATO Research Task Group On Social Media Threat DetectionÂ
When a small cap A.I. company is successfully deploying at the highest levels of global commerce and military, it is a strong sign of the Company’s capabilities that behooves investors to look deeper.Â
That deep dive can begin with our joint interview of Datametrex CEO, Marshall Gunter and President, Jeff Stevens in which we look not only into the past recent success but also into what the future holds in terms of both growth and competition.
Watch this interview on one of your favourite screens or hit play and listen to the audio as you drive. Â
Posted by AGORACOM-JC
at 4:31 PM on Thursday, December 5th, 2019
ZeU Crypto Networks Inc., has filed a new provisional patent entitled “Method and System for Converting Database Applications into Blockchain Applications.”
The new IP provides a convenient method for combining traditional applications with blockchain technology.
Montreal – December 5, 2019 – St-Georges Eco-Mining Corp. (CNSX:SX.CN)(OTC:SXOOF) (FSE:85G1) is pleased to announce that its subsidiary, ZeU Crypto Networks Inc., has filed a new provisional patent entitled “Method and System for Converting Database Applications into Blockchain Applications.” The new IP provides a convenient method for combining traditional applications with blockchain technology.
This method does not require any
modifications to existing applications. On the database layer, we
directly ensure data in the database maintains synchronization with the
data in the blockchain. Traditional enterprise applications are
database-based applications, and all business services are built upon
relational or non-relational databases. A common problem in the process
of migrating from enterprise applications to blockchain applications is
that the overall structure of blockchain is very different from
traditional enterprise applications. Enterprise applications must be
significantly modified or even rewritten to fit the structure of
blockchain’s logic.
This patent provides a method and
system for converting database-based applications into blockchain-based
applications; multiple applications on different nodes can automatically
perform global data consensus to prevent data conflicts. The basic
method is to monitor the database written by applications, extract data
operations from transaction logs, convert the data operations to a
general format, and activate the smart contract on the blockchain to
complete the data consensus check at multiple nodes. Each node monitors
the blocks on blockchain and synchronizes the data back to the database.
In the case of conflicting or illegal data, the data is not able to
pass consensus and synchronize with the other nodes in the blockchain.
The local nodes automatically roll back when detecting invalid data.
Example 1: Electrical Certificate
In this case, when a record is
generated locally, and it needs to be retrieved later for confirmation,
such as legal documents, bank orders, etc. Traditionally a centralized
database has been used to store the data and validate the conflicts.
With the method in this patent, traditional database-based apps could be easily converted to a blockchain-based decentralized system and expanded to multiple organizations.
In a traditional environment, all
apps must be based on the same database to store and verify the data.
With the method in this patent, there is no need to modify the app code,
insert the BC-DB adapter layer between the database and the blockchain
in each node, and then select the fields in the database to
automatically synchronize to all other databases through the blockchain.
If there is a data conflict, the adapter resolves it. All the changes
from DB1 and DB3 are synchronized to DB2, and APP 2 could query all
confirmed data.
Example 2: Supply Chain
For supply chain scenarios, there
may be different participants, like part suppliers, manufacturers,
logistic companies, retailers, banks, etc. Product info data needs to be
shared between different organizations. Suppliers write records for
parts supplied to the manufacturer. Manufacturers write product
information and which parts were used for which product. Logistic
companies write details regarding product transportation. Retailers
write product sales information. The bank needs all the aforementioned
information to issue loans.
By adding an adapter beside each
database, the databases on different nodes could be synchronized and
achieve impressive results. The supply company knows the inventory of
the manufacturer. It thus could prepare parts in advance, thereby
shortening the lead-time. The logistic company could get the product
data even if it is still at the manufacturer, and can arrange vehicles
in advance. The manufacturer receives the retail data to help plan the
manufacturing cycle to better suit market needs. The bank could receive
all the data from the different nodes to detect potential fraud and
issue loans to participants.
St-Georges Eco-Mining Other Corporate Matters
Amended listing statement for ZeU
St-Georges subsidiary, ZeU Crypto
Networks Inc, has filed today an amended listing statement with the
Canadian Securities Exchange that takes into account the recent changes
in short-term debt ratios that were previously holding the process.
Management will keep its shareholders informed on the progress when
material information becomes available.
Missing & Incorrect Information from Latest Press Release
St-Georges would like to correct a
mistake include in the December 1, 2019 Press Release “Closing of First
Tranche of Financing.” Some versions of the press release were
disseminated with the wrong amount being raised. The total amount raised
is $500,100, while the erroneous release mentioned $501,100.
Additionally, one insider subscribing in the private placement was
omitted from the list. Enrico Di Cesare, a director and insider of the
company, subscribed to 300,000 units of the placement for a total of
$30,000.
ON BEHALF OF THE BOARD OF DIRECTORS
“Frank Dumas”
FRANK DUMAS
DIRECTOR & COO, ST-GEORGES ECO-MINING
PRESIDENT & CEO, ZEU CRYPTO NETWORKS.
The
Canadian Securities Exchange (CSE) has not reviewed and does not accept
responsibility for the adequacy or the accuracy of the contents of this
release.
Copyright (c) 2019 TheNewswire – All rights reserved.
Posted by AGORACOM-JC
at 3:20 PM on Thursday, December 5th, 2019
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
mHealth Device Market Rise +35.03% of CAGR By Upcoming Developments + Future Investment
mHealth Device Market is Witnessing Rising Acceptance of Connected Technology Solutions
Mobile health is one of the most disruptive trends ever occurred in the healthcare sector.
mHealth refers to mobile health, one of the most disruptive trends
ever occurred in the healthcare sector. It is a public health practice
supported by mobile devices, commonly used for health services,
information, and data collection through mobile communication devices,
such as mobile phones, computers, tablets or PDAs, and wearable devices
like smartwatches. mHealth is also defined as a sub-segment of eHealth,
which uses ICT (information & communication technology), such as
communications satellites, patient monitors, etc.
The global mHealth device market share is expected to create a valuation of over USD 48,663.2 MN by 2023. In its mHealth market growth analysis, MRFR also asserts that the market would register a massive 35.03% CAGR throughout the forecast period (2017 – 2023).
Research Synopsis
MHealth devices include mobile devices, real-time monitors for vital
signs, and telemedicine. mHealth solutions allow users to access the
collected data to check and maintain the health-related activities,
using technologies such as Bluetooth, mobile network (GSM/GPRS/3G/4G),
and Wi-Fi. Such advantages are encouraging the acceptance of mHealth
devices in growing numbers of healthcare facilities, which increases the
size of the mHealth solutions market globally.
The rapid adoption of portable and smart devices such as tablets and
smartphones is a key driving force for the growth of the connected
healthcare device market services.Besides, advancements in connectivity
and mHealth technology solutions act as a major tailwind for the market
growth. Simultaneously, factors such as rising patient involvement n
personal healthcare and the introduction of connected healthcare
solutions are impacting the growth of the market positively. An increase
in lifestyle disease and benefits of mHealth solutions such as
cost-effectiveness & convenience foster market growth. Furthermore,
raising awareness among patients is driving market growth.
Tags: EKG, mhealth, small cap stocks, stocks, tsx, tsx-v Posted in CardioComm Solutions | Comments Off on CardioComm Solutions $EKG.ca – #Mhealth Device Market to Rise 35% Due to Upcoming Developments + Future Investment $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca
Posted by AGORACOM-JC
at 12:42 PM on Thursday, December 5th, 2019
SPONSOR: New Age Metals Inc.
The company owns one of North America’s largest primary platinum
group metals deposit in Sudbury, Canada. Updated NI 43-101 Mineral
Resource Estimate 2,867,000 PdEq Measured and Indicated Ounces, with an
additional 1,059,000 PdEq Ounces in the Inferred. Learn More.
Palladium zooms past $1,860/oz
Palladium was up 0.3% at $1,845.80 an ounce, after hitting a new high of $1,861.71 earlier in the session.
The metal has been breaking records daily since Nov. 25.
“Palladium positioning is slightly counter-intuitive to the price
action, implicitly confirming heavy OTC interest from the long side,â€
INTL FCStone analyst Rhona O’Connell said in a note. “After weak longs
were shaken out in early November another push to the upside is now
approaching resistance from the uptrend.â€
Concerns that supply of the metal used in car exhaust systems could
run out has helped to lift prices by more than 47% this year alone,
despite a weakening auto sector.
Silver shed 0.4% to $16.95 an ounce and platinum gained 0.4% to $903.51.
Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
Recently launched CBD extraction facility
First extraction system capacity = 6,000 Kg per year.
CBD based products are poised to be a $20B global industry by 2022
Medical cannabis is poised to be a $100B global industry by 2025
——————
Researchers Leverage CBD’s Medical Properties to Fight a Plethora of Ailments
Over the past year, demand for cannabidiol, or CBD, has been increasing at an exponential pace.
In particular, the U.S. experienced massive growth in CBD sales after it passed the Farm Bill in late 2018, legalizing the commercialization of hemp, which CBD is derived from.
CBD is the active chemical found within the hemp plant, which falls under the cannabis family
NEW YORK, Dec. 4, 2019 — Over the past year, demand for cannabidiol, or CBD, has been increasing at an exponential pace. In particular, the U.S. experienced massive growth in CBD sales after it passed the Farm Bill in late 2018, legalizing the commercialization of hemp, which CBD is derived from. CBD is the active chemical found within the hemp plant, which falls under the cannabis family.
Similarly, marijuana also falls under the cannabis family, but
marijuana and hemp are widely different in their biological makeup, as
marijuana’s active chemical is THC, which is generally known to induce
psychoactive effects. Meanwhile, CBD does not cause mind-altering
effects but instead stimulates relaxation. Moreover, extensive clinical
trials have also concluded that CBD can be effectively used in
healthcare to treat a variety of medical conditions.
Consequently, many countries began to move towards legalizing CBD
because of its versatile uses. For instance, researchers have boasted
that CBD can treat symptoms associated with cancer, chronic pain,
Alzheimer’s, multiple sclerosis, and epilepsy. However, in the U.S.,
there is currently only one CBD-based drug approved: Epidiolex.
Epidiolex is used to treat Lennox-Gastaut and Dravet syndromes, which
are two rare epileptic disorders that occur early in adolescence. And
while the U.S. has only approved CBD for epilepsy-related conditions,
other countries have legalized CBD-based drugs to treat other serious
conditions such as HIV/AIDS, depression, and even withdrawal from opioid
drugs.
Nevertheless, it is important to remember that the CBD industry is
still in its infancy stage due to the lack of research authenticating
the benefits of the compound. But researchers around the world are
engaged in clinical trials to rectify this and prove the efficacy of CBD
while promoting it as a next-generation medical treatment. According to
data compiled by Grand View Research, the global cannabidiol market was
valued at USD 1.34 Billion in 2018 and is expected to expand at a CAGR
of 32.6% over the forecast period from 2019 to 2025.
Overall, there are hundreds of studies being conducted to evaluate
the efficacy of CBD. Notably, researchers are advancing studies to
further promote the use of the CBD for Parkinson’s treatment. Currently,
the research on CBD for Parkinson’s is very limited and most studies
are likely small-scale trials. However, the handful of studies that have
been conducted suggest that CBD can have positive effects when dealing
with nonmotor symptoms. According to Healthline, several studies have
hinted that CBD can be used to treat tremors, psychosis, and improve the
overall quality of life for some patients. For example, a small scale
study suggested that CBD may help ease muscle movements, while another
study discovered that CBD reduced the severity of individuals’ suffering
from psychotic symptoms.
Meanwhile, another study suggested that CBD can help suppress sleep
disturbances such as vivid dreams, nightmares, or movement.
Additionally, several researchers even believe that CBD can ultimately
be used to prevent Parkinson’s disease, even as there is currently
insufficient data on the use of CBD on humans to prevent Parkinson’s.
Nevertheless, researchers are actively evaluating the effects of CBD on
protecting the human brain. And while research on CBD is limited, the
small-scale results are highly promising.
As such, CBD clinical trials are anticipated to accelerate in the
shortcoming future. “The work to date on marijuana and cannabinoids has
given promising but conflicting signals,” said Rachel Dolhun, MD, Vice
President, Medical Communications at The Michael J. Fox Foundation for
Parkinson’s Research. “This therapy may represent a future treatment
option for PD, but the correct dose and formulation are not clear, full
side effects and drug interactions are unknown, and benefits have not
been rigorously determined. Future studies should be large and well
designed to provide clear data on the safety and efficacy of marijuana
and cannabinoids in Parkinson’s.”
Tags: CSE, Hemp, Marijuana, stocks, tsx, tsx-v, weed Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca – Researchers Leverage #CBD Medical Properties to Fight a Plethora of Ailments $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca
Posted by AGORACOM-JC
at 3:09 PM on Wednesday, December 4th, 2019
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
How mHealth apps are providing solutions to the healthcare market’s problems
Mobile health is the monitoring and sharing of health information via mobile technology – such as wearables and health tracking apps.
The use of mobile devices and wireless technology to monitor symptoms and deliver care allows physicians to make diagnoses quicker and with fewer errors.Â
Today’s consumers don’t want to solely rely on yearly physicals or
scattered drop-in appointments to monitor their health – they are
seeking more individualized control over the way healthcare is accessed
so that they can analyze personal health data and talk to healthcare
professionals at all times.
By embracing mobile health, or mHealth, patients are able to keep
track of their own health data in real time and inform healthcare
providers of any abnormalities at the push of a button.
What is mHealth (mobile health)?
Mobile health is the monitoring and sharing of health information via mobile technology – such as wearables
and health tracking apps. The use of mobile devices and wireless
technology to monitor symptoms and deliver care allows physicians to
make diagnoses quicker and with fewer errors.
And as tech giants like Apple and Google continue pushing their way into healthcare, mHealth will likely grow in popularity.
mHealth vs telehealth
Telehealth
uses technology to extend the reach of healthcare professionals beyond
traditional clinical settings. It’s a broad term describing how the
healthcare market is taking advantage of digital development to enable
remote care.
Comparatively, mHealth is a subset of telehealth, referring
specifically to the use of mobile technology to inform and educate
consumers on healthcare. It uses mobile devices to monitor patients’
exercise, heart rate, and medication adherence.
Examples of different types of mHealth apps
Mobile health is gaining steam among consumers as Apple and Google
continue to offer an array of mHealth applications on their app stores;
there were more than 318,000 mHealth apps available for download
worldwide as of November 2017. Some of the most common categories of
mHealth apps include:
Diabetes
Pregnancy
Weight loss
Chronic illness
Benefits of mHealth app solutions
Stakeholders across the healthcare industry are looking to tap into
the mHealth opportunity as Mobile health applications are beginning to
integrate electronic health records (EHRs) and other wearable tech devices.
According to Business Insider Intelligence, nearly half of all
mHealth app publishers integrate with EHRs in order to provide a
detailed representation of a patient’s health or medical history.
Stakeholders across the healthcare industry are looking to tap into the mHealth opportunity.
Business Insider Intelligence
Healthcare providers could reduce appointment costs by taking
advantage of mHealth applications – which lowers the risk of patient
rehabilitation. Instead of staying in a healthcare facility post
surgical discharge, patients could utilize mHealth apps for recovery
instructions and medication reminders.
Payers – which handle the financial aspects of healthcare – can also
capitalize on mHealth cost benefits. According to a 2018 Leavitt
Partners report, clinical care only accounts for 20% of health, and
social determinants account for the remainder.
Health insurance providers could develop mobile apps that provide
consumers with health education and send reminders to purchase healthy
food – keeping patients largely responsible for their own healthcare.
mHealth industry trends & technologies
One concern consumers have regarding mHealth solutions has to do with
data-sharing practices among multiple technologies and applications.
According to Business Insider Intelligence, 79% of 24 top-rated mHealth
apps shared user data with 55 entities, like app developers and third
parties.
Despite privacy concerns however, Business Insider Intelligence
predicts that as big tech companies like Apple and Samsung continue to
generate their own health features in smartphones, the adoption of
mHealth apps will continue to grow.
In fact, Apple grew wearable revenue 42% year-over-year in 2018 and has the potential to hit $15 billion in healthcare-related revenue by 2021.
Business Insider Intelligence’s Digital Health Ecosystem Report
explores digital disruption in healthcare, detailing how technologies
like mobile health apps are reshaping the industry. The report outlines
the role of major players in healthcare from payers to consumers –
explaining how they’re all being affected amid the industry’s digital
awakening.
